United Therapeutics (UTHR) Other Working Capital Changes (2009 - 2014)
United Therapeutics (UTHR) posted Other Working Capital Changes of -$27.0 million for Q1 2026, down 127.49% sequentially from $98.2 million in Q4 2025, and up 79.93% YoY from -$15.0 million in Q1 2025.
United Therapeutics (UTHR) Other Working Capital Changes (2009 - 2014) Analysis & Trends
United Therapeutics has reported Other Working Capital Changes for 13 years, with the latest figure at -$27.0 million in Q1 2026.
- Quarterly Other Working Capital Changes rose 79.93% year-over-year to -$27.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $188.4 million (up 379.11% YoY) and the FY2025 annual result came in at $80.9 million, up 1051.76% from the prior year.
- Other Working Capital Changes eased to -$27.0 million in Q1 2026 per UTHR's latest filing, from $98.2 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $10.7 million in Q4 2014 and troughed at -$5.0 million in Q3 2011.
- A 5-year average of $1.6 million and a median of $1.5 million in 2011 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes surged 648.41% in 2022, then sank 1086.05% in 2024.
- Over 5 years, Other Working Capital Changes stood at $94.3 million in 2022, then plunged by 124.5% to -$23.1 million in 2023, then declined by 16.88% to -$27.0 million in 2024, then surged by 463.7% to $98.2 million in 2025, then sank by 127.49% to -$27.0 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$27.0 million, $98.2 million, and -$67.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 10.67 Mn |
| Dec 31, 2014 | 10.67 Mn |
| Dec 31, 2014 | 10.67 Mn |
| Sep 30, 2014 | -3.32 Mn |
| Sep 30, 2014 | -3.32 Mn |
| Sep 30, 2014 | -3.32 Mn |
| Jun 30, 2014 | -231,000.00 |
| Jun 30, 2014 | -231,000.00 |
| Jun 30, 2014 | -231,000.00 |
| Mar 31, 2014 | -500,000.00 |
| Mar 31, 2014 | -500,000.00 |
| Mar 31, 2014 | -500,000.00 |
| Dec 31, 2013 | 9.67 Mn |
| Dec 31, 2013 | 9.67 Mn |
| Dec 31, 2013 | 9.67 Mn |
| Sep 30, 2013 | -469,000.00 |
| Sep 30, 2013 | -469,000.00 |
| Sep 30, 2013 | -469,000.00 |
| Jun 30, 2013 | -923,000.00 |
| Jun 30, 2013 | -923,000.00 |